Merci Liquid Biopsy

MarketWatch: Precede Biosciences Launches Precede Bio Insight(TM), a Genome-Wide Liquid Biopsy for Functional Tumor Biology at AACR 2026

Merci Liquid Biopsy 1

Precede Biosciences Launches Precede Bio Insight(TM), a Genome-Wide Liquid Biopsy for Functional Tumor Biology at AACR 2026

Merci Liquid Biopsy 2

A liquid biopsy is a blood test designed to detect cancer cells or DNA fragments of cancer cells circulating in the bloodstream. While a liquid biopsy may be useful for spotting several types of ...

MedPage Today: Liquid Biopsy in Gynecological Cancers: Q&A on Molecular Rationale, Technical Considerations, and Real-World Implications for Treatment

—Canio Martinelli, MD, Director of Clinical and Translational Research, Sbarro Health Research Organization at Temple University in Philadelphia, discusses this rapidly evolving field. Liquid biopsy ...

Liquid Biopsy in Gynecological Cancers: Q&A on Molecular Rationale, Technical Considerations, and Real-World Implications for Treatment

Merci Liquid Biopsy 6

MarketWatch: nRichDX and Hamilton Advance Automated Liquid Biopsy Sample Prep Solution with Unprecedented Capability

nRichDX and Hamilton Advance Automated Liquid Biopsy Sample Prep Solution with Unprecedented Capability

Liquid biopsy holds enormous potential in precision oncology—enabling non-invasive, real-time insights into tumor genomics that can guide more accurate treatment decisions. However, its global ...

Merci Liquid Biopsy 9

Join us for this presentation about digital PCR (dPCR) and it use in rare target detection in liquid biopsies. Identification and tracking of cancer-causing mutations via liquid biopsy are ...

STAT: Address liquid biopsy disparities today to ensure equity in outcomes tomorrow

The American Journal of Managed Care: Liquid Biopsy Advances: Vital Role in Biomarker Testing in Lung Cancer

Renal & Urology News: ‘Liquid Biopsy’ Reduces Unnecessary Invasive Biopsies After Kidney Transplantation

Merci Liquid Biopsy 13

In a trial, a model gauging transplant rejection risk using donor-derived cell-free DNA and other parameters safely reduced invasive biopsies. A ‘liquid biopsy’ incorporating donor-derived cell-free ...